Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study. (Q51265899)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 November 2014

Language	Label	Description	Also known as
English	Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study.	scientific article published on 21 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

hospitalization

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

5

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

3

object named as

Eva Rönmark

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

4

object named as

Bo Lundbäck

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

Sven-Arne Jansson

1

object named as

Sven-Arne Jansson

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

language of work or name

0 references

publication date

21 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

COPD: Journal of Chronic Obstructive Pulmonary Disease

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

12

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

4

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

381-389

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

Global burden of COPD: risk factors, prevalence, and future trends

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Definition, epidemiology and natural history of COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Global burden of COPD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Health-related quality of life is related to COPD disease severity

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Health economic costs of COPD in Sweden by disease severity--has it changed during a ten years period?

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Present and future costs of COPD in Iceland and Norway: results from the BOLD study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Excessive costs of COPD in ever-smokers. A longitudinal community study.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Costs of chronic bronchitis and COPD: a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Predicting the costs of managing patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Cost impact of COPD in Japan: opportunities and challenges?

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Economic analysis of the Confronting COPD survey: an overview of results

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

COPD in the working age population: the economic impact on both patients and government

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Recent trends in physician diagnosed COPD in women and men in the UK.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Costs of COPD in Sweden according to disease severity.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Cost differences for COPD with and without physician-diagnosis.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Mortality in COPD: Role of comorbidities.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Hospitalizations and mortality in the Lung Health Study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Cardiovascular comorbidity in COPD: systematic literature review.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Incidence of physician-diagnosed asthma in adults--a real incidence or a result of increased awareness? Report from The Obstructive Lung Disease in Northern Sweden Studies.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Repeatability of health economic data in COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

COPD and the Risk of Depression

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Recommendations for epidemiological studies on COPD

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.974089

21 January 2018

Identifiers

10.3109/15412555.2014.974089

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/25415366

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51265899&oldid=1855741753"